ReviewNature reviews. Immunology2015
Immune biomarkers: the promises and pitfalls of personalized medicine.
Review in Nature reviews. Immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review.Frontiers in immunology · 2018Pooled it
- PatientProfiler: building patient-specific signaling models from proteogenomic data.Molecular systems biology · 2025Article
- Recommendations for the use of biomarkers for the management of adults with sepsis: a scoping review and critical appraisal.BMJ open · 2025Article
- A global metric of immune health.Nature medicine · 2024Article
- Restricting datasets to classifiable samples augments discovery of immune disease biomarkers.Nature communications · 2024Article
- Immunological characterization of pleural effusions in pediatric patients.Frontiers in immunology · 2024Article
- Article
- Influence of cytotoxic T lymphocyte antigen 4 genetic variants on acute rejection in kidney transplant patients: precision medicine perspective.Journal of diabetes and metabolic disorders · 2022Article
- Irradiation immunity interactions.Journal of medical imaging and radiation oncology · 2022Review
- A virtual host model of Mycobacterium tuberculosis infection identifies early immune events as predictive of infection outcomes.Journal of theoretical biology · 2022Article
- The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2022Review
- Evaluation of exosomal non-coding RNAs in cancer using high-throughput sequencing.Journal of translational medicine · 2022Review
- Deep phenotyping of T cell populations under long-term treatment of tacrolimus and rapamycin in patients receiving renal transplantations by mass cytometry.Clinical and translational medicine · 2021Article
- A Combined microRNA and Chemokine Profile in Urine to Identify Rejection After Kidney Transplantation.Transplantation direct · 2021Article
- Precision Medicine in Kidney Transplantation: Just Hype or a Realistic Hope?Transplantation direct · 2021Article
- Tumor Biomarker In-Solution Quantification, Standard Production, and Multiplex Detection.Journal of immunology research · 2021Review
- Prediction scores for risk of allograft loss in patients receiving kidney transplants: nil satis nisi optimum.Clinical kidney journal · 2020Article
- Impact of treatment on cellular immunophenotype in MS: A cross-sectional study.Neurology(R) neuroimmunology & neuroinflammation · 2020Article
- Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus.Nature medicine · 2020Article
- Grand Challenges in Infectious Diseases: Are We Prepared for Worst-Case Scenarios?Frontiers in microbiology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Substantial progress in molecular immunology, coupled with an increasing focus on translational research and an enthusiasm for personalized medicine, has resulted in a rapid expansion in the field of immune biomarkers in recent years. In this Science and Society article, we provide a conceptual overview of the field and discuss the progress that has been made so far, as well as the future potential in the context of the scientific, logistical, financial, legal and ethical framework within which this research is being carried out and translated into clinical use.
Indexed as
Identifiers
25814400What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.